Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018

QR Code

Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018

BACKGROUND: The National Colorectal Cancer Roundtable, a national coalition of public, private, and voluntary organizations, has recently announced an initiative to increase colorectal cancer (CRC) screening rates in the United States to 80% by 2018. The authors evaluated the potential public health...

Full description

Bibliographic Details
Main Authors:	Meester, R., Doubeni, C., Zauber, A., Goede, S., Levin, T., Corley, D., Jemal, A., Lansdorp-Vogelaar, Iris
Format:	Journal Article
Published:	John Wiley & Sons, Inc. 2015
Online Access:	http://hdl.handle.net/20.500.11937/49908

Similar Items

Colorectal cancer deaths attributable to nonuse of screening in the United States
by: Meester, R., et al.
Published: (2015)

Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test
by: Meester, R., et al.
Published: (2016)

Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: A microsimulation model
by: Meester, R., et al.
Published: (2015)

Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)

Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis
by: Van Hees, F., et al.
Published: (2014)

Colorectal cancer screening in Australia
by: Kuipers, E., et al.
Published: (2017)

Cost-effectiveness of colorectal cancer screening
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)

State disparities in colorectal cancer mortality patterns in the United States
by: Naishadham, D., et al.
Published: (2011)

Cost-savings to medicare from pre-medicare colorectal cancer screening
by: Goede, S., et al.
Published: (2015)

The impact of stratifying by family history in colorectal cancer screening programs
by: Goede, S., et al.
Published: (2015)

Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer
by: Gini, A., et al.
Published: (2018)

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Introduction
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2017)

The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: A modeling study
by: Van Hees, F., et al.
Published: (2014)

Validation of Models Used to Inform Colorectal Cancer Screening Guidelines
by: Rutter, C., et al.
Published: (2015)

Development of new non-invasive tests for colorectal cancer screening: The relevance of information on adenoma detection
by: Haug, U., et al.
Published: (2015)

Immunochemical faecal occult blood testing to screen for colorectal cancer: Can the screening interval be extended?
by: Haug, U., et al.
Published: (2016)

The value of models in informing resource allocation in colorectal cancer screening: The case of the Netherlands
by: Van Hees, F., et al.
Published: (2015)

Clarifying differences in natural history between models of screening: The case of colorectal cancer
by: Van Ballegooijen, M., et al.
Published: (2011)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2013)

Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness
by: Van Hees, F., et al.
Published: (2015)

Faecal immunochemical tests versus guaiac faecal occult blood tests: What clinicians and colorectal cancer screening programme organisers need to know
by: Tinmouth, J., et al.
Published: (2015)

Sojourn time of preclinical colorectal cancer by sex and age: Estimates from the german national screening colonoscopy database
by: Brenner, H., et al.
Published: (2011)

Estimation of benefits, burden, and harms of colorectal cancer screening strategies: Modeling study for the US preventive services Task Force
by: Knudsen, A., et al.
Published: (2016)

Cost effectiveness of surveillance for GI cancers
by: Omidvari, A., et al.
Published: (2016)

Optimal colorectal cancer screening in states' low-income, uninsured populations - The case of South Carolina
by: Van Der Steen, A., et al.
Published: (2015)

Integrating personalised genomics into risk stratification models of population screening for colorectal cancer
by: Cenin, Dayna, et al.
Published: (2017)

Assessment of a cancer screening program
by: Rabeneck, L., et al.
Published: (2015)

Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program
by: Wieten, E., et al.
Published: (2016)

Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population
by: Cenin, Dayna, et al.
Published: (2018)

Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013)

Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening
by: Grobbee, E., et al.
Published: (2015)

Adherence to colorectal cancer screening: Four rounds of faecal immunochemical test-based screening
by: Van Der Vlugt, M., et al.
Published: (2017)

How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
by: Wilschut, J., et al.
Published: (2011)

Fecal immunochemical test-based colorectal cancer screening: The gender dilemma
by: Grobbee, E., et al.
Published: (2017)

The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions
by: Kroep, S., et al.
Published: (2015)

Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy
by: Stock, C., et al.
Published: (2011)

A systematic comparison of microsimulation models of colorectal cancer: The role of assumptions about adenoma progression
by: Kuntz, K., et al.
Published: (2011)

Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
by: Wilschut, J., et al.
Published: (2011)

Cannot write session to /tmp/vufind_sessions/sess_l82ro620e5hj0mdqkdai85ht4l